Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinomaGREER, Robert O; SAID, Sherif; SHROYER, Kenneth R et al.Oral oncology (1997). 2007, Vol 43, Num 8, pp 735-741, issn 1368-8375, 7 p.Article

The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancerVARELLA-GARCIA, Marileila; AKDUMAN, Bulent; SUNPAWERAVONG, Patrapim et al.Urologic oncology. 2004, Vol 22, Num 1, pp 16-19, issn 1078-1439, 4 p.Article

TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic originsVAN BOKHOVEN, Adrie; VARELLA-GARCIA, Marileila; KORCH, Christopher et al.Cancer research (Baltimore). 2001, Vol 61, Num 17, pp 6340-6344, issn 0008-5472Article

Widely used prostate carcinoma cell lines share common originsVAN BOKHOVEN, Adrie; VARELLA-GARCIA, Marileila; KORCH, Christopher et al.The Prostate. 2001, Vol 47, Num 1, pp 36-51, issn 0270-4137Article

Chromosomal aneuploidy precedes morphological changes and supports multifocality in head and neck lesionsHONG AI; BARRERA, Jose E; MEYERS, Arlen D et al.The Laryngoscope. 2001, Vol 111, Num 10, pp 1853-1858, issn 0023-852XArticle

Diagnostic Assays for Identification of Anaplastic Lymphoma Kinase―Positive Non―Small Cell Lung CancerWEICKHARDT, Andrew J; AISNER, Dara L; FRANKLIN, Wilbur A et al.Cancer. 2013, Vol 119, Num 8, pp 1467-1477, issn 0008-543X, 11 p.Article

Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapyBUNN, Paul A; DZIADZIUSZKO, Rafal; VARELLA-GARCIA, Marileila et al.Clinical cancer research. 2006, Vol 12, Num 12, pp 3652-3656, issn 1078-0432, 5 p.Article

Gene amplification is a mechanism of Six1 overexpression in breast cancerREICHENBERGER, Kelly J; COLETTA, Ricardo D; SCHULTE, Aline P et al.Cancer research (Baltimore). 2005, Vol 65, Num 7, pp 2668-2675, issn 0008-5472, 8 p.Article

HER2/neu expression in malignant lung tumorsHIRSCH, Fred R; FRANKLIN, Wilbur A; VEVE, Robert et al.Seminars in oncology. 2002, Vol 29, Num 1, pp 51-58, issn 0093-7754, SUP4Article

Identification of two new translocations that disrupt the AML1 geneRICHKIND, Kathleen; HROMAS, Robert; LYTLE, C et al.Cancer genetics and cytogenetics. 2000, Vol 122, Num 2, pp 141-143, issn 0165-4608Article

Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epitheliumJACOBSEN, Britta M; HARRELL, J. Chuck; JEDLICKA, Paul et al.Cancer research (Baltimore). 2006, Vol 66, Num 16, pp 8274-8279, issn 0008-5472, 6 p.Article

Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose― and sequence―dependent mannerFLAIG, Thomas W; SU, Lih-En; MCCOACH, Caroline et al.BJU international (Papier). 2009, Vol 103, Num 12, pp 1729-1737, issn 1464-4096, 9 p.Article

Six1 Overexpression in Mammary Cells Induces Genomic Instability and Is Sufficient for Malignant TransformationCOLETTA, Ricardo D; CHRISTENSEN, Kimberly L; ALICALIZZI, Douglas S et al.Cancer research (Baltimore). 2008, Vol 68, Num 7, pp 2204-2213, issn 0008-5472, 10 p.Article

Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinomaSUNPAWERAVONG, Patrapim; SUNPAWERAVONG, Somkiat; PUTTAWIBUL, Puttisak et al.Journal of cancer research and clinical oncology. 2005, Vol 131, Num 2, pp 111-119, issn 0171-5216, 9 p.Article

Molecular and cytogenetic analyses on brazilian youths with Pervasive Developmental DisordersHIGINO ESTECIO, Marcos Roberto; FETT-CONTE, Agnes Cristina; VARELLA-GARCIA, Marileila et al.Journal of autism and developmental disorders. 2002, Vol 32, Num 1, pp 35-41, issn 0162-3257Article

HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary TumorsMENGHONG SUN; BEHRENS, Carmen; WISTUBA, Ignacio I et al.Clinical cancer research (Print). 2009, Vol 15, Num 15, pp 4829-4837, issn 1078-0432, 9 p.Article

Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients With Advanced Non-Small-Cell Lung Cancer and Poor Performance StatusGOSS, Glenwood; FERRY, David; ZARENDA, Marc et al.Journal of clinical oncology. 2009, Vol 27, Num 13, pp 2253-2260, issn 0732-183X, 8 p.Article

Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization- : Why, when, and how?DZIADZIUSZKO, Rafal; HIRSCH, Fred R; VARELLA-GARCIA, Marileila et al.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4409s-4415s, 2Conference Paper

The use of trastuzumab in thetreatment of hormone refractory prostate cancer; Phase II trialZIADA, Ali; BARQAWI, Albaha; GLODE, L. Michael et al.The Prostate. 2004, Vol 60, Num 4, pp 332-337, issn 0270-4137, 6 p.Article

Diphtheria Toxin―Epidermal Growth Factor Fusion Protein DAB₃₈₉EGF for the Treatment of Bladder CancerXIAOPING YANG; KESSLER, Elizabeth; MICHAEL GLODE, L et al.Clinical cancer research (Print). 2013, Vol 19, Num 1, pp 148-157, issn 1078-0432, 10 p.Article

Genetic Abnormalities of the EGFR Pathway in African American Patients With Non-Small-Cell Lung CancerLEIDNER, Rom S; PINGFU FU; HIRSCH, Fred R et al.Journal of clinical oncology. 2009, Vol 27, Num 33, pp 5620-5626, issn 0732-183X, 7 p.Article

Translocation (11;19)(q23;p13.3) associated with a novel t(5;16) (q13;q22) in a patient with acute myelocytic leukemiaVENDRAME-GOLONI, Cristina Benitez; VARELLA-GARCIA, Marileila; BORDUCHI CARVALHO-SALLES, Andréa et al.Cancer genetics and cytogenetics. 2003, Vol 141, Num 1, pp 71-74, issn 0165-4608, 4 p.Article

Native and Rearranged ALK Copy Number and Rearranged Cell Count in Non-Small Cell Lung Cancer: Implications for ALK Inhibitor TherapyCAMIDGE, D. Ross; SKOKAN, Margaret; DOEBELE, Robert C et al.Cancer. 2013, Vol 119, Num 22, pp 3968-3975, issn 0008-543X, 8 p.Article

Detection of Circulating Tumor Cells in Metastatic and Clinically Localized Urothelial CarcinomaFLAIG, Thomas W; WILSON, Shandra; VAN BOKHOVEN, Adrie et al.Urology (Ridgewood, NJ). 2011, Vol 78, Num 4, pp 863-867, issn 0090-4295, 5 p.Article

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerMASSARELLI, Erminia; VARELLA -GARCIA, Marileila; XIMING TANG et al.Clinical cancer research. 2007, Vol 13, Num 10, pp 2890-2896, issn 1078-0432, 7 p.Article